CUPR

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Jul 31, 6:30 PMLow-float momentum trading surges Cuprina (CUPR) 20.11% with no new catalyst

Peers: GCTK LUCY NXGL BNGO RGNT ZJYL FEMY RVP HBIO MLSS

Scroll to Statements

Index	-
Market Cap	2.63M
Enterprise Value	0.59M
Income	-3.58M
Sales	0.04M
Book/sh	1.47
Cash/sh	2.63
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	10
IPO	Apr 10, 2025

P/E	-
Forward P/E	-
PEG	-
P/S	65.75
P/B	1.95
P/C	1.09
P/FCF	-
EV/EBITDA	-
EV/Sales	14.75
Quick Ratio	2.35
Current Ratio	2.35
Debt/Eq	0.10
LT Debt/Eq	0.07
Option/Short	No / Yes

EPS (ttm)	-1.34
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-65.95% -75.01%
Sales past 3/5Y	-2.38% -3.22%
EPS Y/Y TTM	-208.64%
Sales Y/Y TTM	6.30%
EPS Q/Q	-223.87%
Sales Q/Q	277.69%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	65.66%
Insider Trans	0.00%
Inst Own	2.15%
Inst Trans	44.41%
ROA	-90.82%
ROE	-1082.72%
ROIC	-85.52%
Gross Margin	-54.48%
Oper. Margin	-9692.62%
Profit Margin	-9376.19%
SMA20	-26.69%
SMA50	-26.93%
SMA200	-27.51%
Trades

Shs Outstand	0.92M
Shs Float	0.92M
Short Float	0.39%
Short Ratio	0.00
Short Interest	0.00M
52W High	76.00 -96.24%
52W Low	1.76 62.20%
Volatility	39.85% 17.44%
ATR (14)	0.86
RSI (14)	39.31
Beta	-0.38
Rel Volume	0.02
Avg Volume	3.12M
Volume	22,380

Perf Week	-20.92%
Perf Month	-50.52%
Perf Quarter	41.49%
Perf Half Y	-15.60%
Perf YTD	-10.81%
Perf Year	-95.64%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	2.92
Price	2.85
Change	-2.23%

Jun-15-26 01:40PM	Why Did CUPR Stock Surge Over 150% Today? (Stocktwits) +111.84%
09:00AM	Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots - the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product (GlobeNewswire)
Jun-12-26 09:00AM	Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire) +64.73%
May-29-26 12:55PM	Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing (GlobeNewswire) -27.27%
May-22-26 10:50AM	Cuprina Holdings announces 1-for-8 Share Consolidation (GlobeNewswire)
08:30AM	Loading…
Mar-11-26 08:30AM	Cuprina Holdings Announces Key Regulatory Milestone in Saudi Arabia and Strengthens Global Scientific Advisory Board (GlobeNewswire) +8.11%
Dec-09-25 08:30AM	Cuprina Holdings (Cayman) Limited Announces Financial Results for the Six Months Ended June 30, 2025, and Strategic Initiatives for 2026 Growth (GlobeNewswire) -6.62%
Dec-05-25 03:14PM	Nasdaq Lists Some Tiny IPOs That Go Up in Flames. Regulators Are Cracking Down. (Barrons.com)
Nov-28-25 08:30AM	Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency (GlobeNewswire)
Nov-18-25 08:30AM	Cuprina forms Joint Venture Company with Aiodine Laboratory to Develop and Market Novel Iodine-based Solution as New Wound Care Therapy (GlobeNewswire)
Oct-27-25 08:40AM	Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies (GlobeNewswire) +19.07%
Oct-06-25 08:30AM	Cuprina to Present Live, Answer Questions, at Skyline Signature Series on October 8th, 2025, at 11:00 AM ET (GlobeNewswire)
Sep-09-25 08:05AM	Cuprina Secures Exclusive Rights to Southeast Asia's First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology (GlobeNewswire) +12.23%
Aug-18-25 08:00AM	Cuprina Reaffirms Commitment to Shareholders and Patients Following Recent Stock Market Activity (GlobeNewswire) +9.24%
Jul-21-25 09:00AM	Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market (GlobeNewswire) +5.02%
08:00AM	Loading…
Jun-30-25 08:00AM	Cuprina Provides Update on Research Studies with Three Leading Education Institutes (GlobeNewswire)
Jun-04-25 08:00AM	Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries (GlobeNewswire)
May-08-25 01:05PM	Cuprina Holdings Announces Closing of Underwriter's Over-Allotment Option in Connection with Initial Public Offering (GlobeNewswire) -7.17%
May-06-25 10:45AM	Cuprina Holdings obtains dealer license for IVF media production facility (TipRanks) +5.38%
May-05-25 12:29PM	Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd. (GlobeNewswire) -9.87%
12:27PM	Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering (GlobeNewswire)
12:24PM	Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering (GlobeNewswire)
Apr-12-25 01:30AM	U.S. IPO Weekly Recap: Flurry Of Small Issuers List, Despite Heightened Market Volatility (Seeking Alpha)
Apr-11-25 11:07AM	Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering (GlobeNewswire) +7.95%
Apr-10-25 08:35AM	Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering (GlobeNewswire)

Cuprina Holdings (Cayman) Ltd. engages in the manufacturing, sale, and supply of medical devices to manage and accelerate healing and closure of chronic wounds. Its products include nature-based bioactive, in the form of advanced wound dressings, derived from sustainable sources. The company was founded by Carl Marc Baptista on August 28, 2019 and is headquartered in Singapore.

CEO & DirectorMr. Yong Qi Quek

Chief Financial OfficerMr. Tat Jing Chan

Medical & Scientific DirectorDr. Ronald Sherman

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Cuprina Holdings (Cayman) Ltd

Upgrade your Finviz experience